Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -619 | -743 | -1,303 | 216 | -4,410 |
| Depreciation Amortization | 66 | 166 | 252 | 169 | 11 |
| Accounts receivable | -1 | -41 | 10 | -21 | -38 |
| Accounts payable and accrued liabilities | -19 | -478 | 392 | 81 | 99 |
| Other Working Capital | -65 | 1,092 | -1,375 | -120 | 256 |
| Other Operating Activity | 62 | 519 | 1,171 | -3,002 | 1,439 |
| Operating Cash Flow | $-576 | $515 | $-854 | $-2,677 | $-2,643 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4 | -66 | -11 | 2,113 | -122 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -158 |
| Investing Cash Flow | $4 | $-66 | $-11 | $2,113 | $-279 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 231 | N/A | 400 | 566 | N/A |
| Common Stock Issued | N/A | N/A | 1,227 | N/A | N/A |
| Other Financing Activity | -5 | -706 | -40 | -220 | 1,058 |
| Financing Cash Flow | $226 | $-706 | $1,586 | $346 | $1,058 |
| Beginning Cash Position | 532 | 788 | 67 | 286 | 2,150 |
| End Cash Position | 185 | 532 | 788 | 67 | 286 |
| Net Cash Flow | $-347 | $-256 | $721 | $-219 | $-1,864 |
| Free Cash Flow | |||||
| Operating Cash Flow | -576 | 515 | -854 | -2,677 | -2,643 |
| Capital Expenditure | -15 | -66 | -11 | -87 | -122 |
| Free Cash Flow | -591 | 449 | -865 | -2,765 | -2,764 |